Skip to main content

Posts

Showing posts with the label biotechonology

SAGE Therapeutics

A report from Fierce BioTech : Third Rock Ventures Launches SAGE Therapeutics to Address CNS Disorders with Critical Unmet Needs Posted October 18, 2011 [snippet] "Third Rock Ventures, LLC today announced the formation of SAGE Therapeutics. The company was launched with a $35 million Series A financing. SAGE's efforts focus on advancing a broad pipeline of new, critically needed treatments for some of the most disabling central nervous system (CNS) disorders such as schizophrenia, depression, pain and traumatic brain injury (TBI). SAGE Therapeutics is founded on a proprietary Positive and Negative Allosteric Modulator (PANAM) chemistry platform that will enable the rapid development of a novel class of allosteric receptor modulators. Steven Paul, M.D., the former executive vice president for science and technology and president of Lilly Research Laboratories and a former scientific director of the National Institute of Mental Health (NIMH) and Douglas Covey, Ph.D., professor o...
Post a Comment
Read more

Upcoming Event: Genesis Conference 2009 (London, 10th-11th December)

The Genesis 2009 Conference will take place on the 10th and 11th of December at the Queen Elizabeth II Conference Centre (London). From the website: " Welcome to Genesis 2009 – “Back in focus!” The challenges of the economic downturn stimulated us to build innovative new partnerships at Genesis last year. The resultant exciting mix of business and science is something many have only dreamed of. This will be retained for 2009 with a streamlined approach for delegates to maximise the return on your investment in participating." For details, please see the conference website
Post a Comment
Read more

Clinical Trials: Upcoming Conference

Early next year: Third Annual Patient Recruitment in Clinical Trials conference, to be held 08th-09th March, 2010 in Philadelphia, PA. From the conference webpage: "Patient recruitment and retention are critical to drug development programs. Patient recruitment if not adequately planned for can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for your analysis and subsequent filings. In order to optimize both you have to have a plan. This conference is intended to cover the topics one should consider when drafting and strategically implementing a patient recruitment and retention plan for a clinical development program." Please see conference webpage for details.
Post a Comment
Read more